Disclosure of Disease Risks in Genomic Research: Under what circumstances should (not) genomic researchers disclose results about disease risks?: Difference between revisions
Line 26: | Line 26: | ||
==Program== | ==Program== | ||
<br /><br /> | |||
'''Welcome Remarks'''<br /> | |||
- [http://nih.upm.edu.ph/index.php?option=com_content&view=article&id=71&Itemid=68 Dr. Vicente Y. Belizario, Jr.] <br /> | |||
Executive Director, UP Manila National Institutes of Health<br /><br /> | |||
'''Opening Remarks'''<br /> | |||
[http://nih.upm.edu.ph/index.php?option=com_content&view=article&id=71&Itemid=68 Dr Carmencita David Padilla] <br /> | |||
Executive Director, [http://pgc.up.edu.ph Philippine Genome Center]<br /><br /> | |||
"Disclosure of Disease Risks in Genomic Research: Under what circumstances should (not) genomic researchers disclose results about disease risks?" <br /> [http://www.bioethics.nih.gov/people/cv/Lie_CV_Nov11.pdf Dr Reidar K. Lie] <br /> | |||
Adjunct Research Fellow, US NIH<br /><br /> | |||
"Reviewing Genetic and Genomic Research: Issues and Challenges" <br /> | |||
[https://sites.google.com/a/post.upm.edu.ph/dbmb/home/faculty-and-staff/lmd Dr Leslie Michelle M. Dalmacio] <br /> | |||
UP Manila Research Ethics Board<br /><br /> | |||
Reactor | |||
[http://rbd.stluke.com.ph/microsites/page.php?micrositeID=6&parentPageID=&pageID=88 Dr Filipinas Natividad] <br /> | |||
VP for Research and Biotechnology Division, St Luke's Medical Ctr | |||
<br /><br /> | |||
'''Open Discussions''' | |||
Prof. Peter A. Sy (Moderator) <br /> | |||
PGC ELSI Program Director<br /><br /> | |||
'''Closing Remarks'''<br /> | |||
Dr. Jacinto Blas Mantaring III<br /> | |||
UPMREB Chair<br /><br /> | |||
Dr. Marita V. Reyes<br /> | |||
Scientific Adviser, PGC ELSI Program | |||
<br /><br /> | <br /><br /> | ||
Revision as of 19:09, 24 November 2012
An ELSI Colloquium on "Disclosure of Disease Risks in Genomic Research: Under what circumstances should (not) genomic researchers disclose results about disease risks?"
10 December 2012 (Monday), 2pm
NIH Conference Room (map)
University of the Philippines - Manila
Webpage shortcut: goo.gl/xszDH
Online Registration. Please register asap, as seats are limited. Confirmation will be needed.
Resource Person
Dr Reidar K. Lie
Adjunct Research Fellow
Department of Bioethics
Clinical Center
National Institutes of Health, USA
Organizers
- PGC ELSI Program
- UP Manila Research Ethics Board
- UP Manila National Institutes of Health
Program
Welcome Remarks
- Dr. Vicente Y. Belizario, Jr.
Executive Director, UP Manila National Institutes of Health
Opening Remarks
Dr Carmencita David Padilla
Executive Director, Philippine Genome Center
"Disclosure of Disease Risks in Genomic Research: Under what circumstances should (not) genomic researchers disclose results about disease risks?"
Dr Reidar K. Lie
Adjunct Research Fellow, US NIH
"Reviewing Genetic and Genomic Research: Issues and Challenges"
Dr Leslie Michelle M. Dalmacio
UP Manila Research Ethics Board
Reactor
Dr Filipinas Natividad
VP for Research and Biotechnology Division, St Luke's Medical Ctr
Open Discussions
Prof. Peter A. Sy (Moderator)
PGC ELSI Program Director
Closing Remarks
Dr. Jacinto Blas Mantaring III
UPMREB Chair
Dr. Marita V. Reyes
Scientific Adviser, PGC ELSI Program
Inquiries
Please direct them to
psy@kssp.upd.edu.ph
See Also
“Ethical, Legal, Social Issues” (ELSI) Program, Philippine Genome Center